ROS1 in non-small-cell lung carcinoma: A narrative review

ROS1 in non-small-cell lung carcinoma: A narrative review

ROS1 rearranged non-small-cell lung cancer (NSCLC) is a distinct molecular subtype of NSCLC, accounting for 2% of cases. Typically, these are genomic rearrangements resulting in a fusion oncoprotein that causes unabated constitutive signaling. Patients with ROS1 rearranged NSCLC have distinct clinic...

Full description

Bibliographic Details
Main Authors: Shrinidhi Nathany, Ullas Batra, Rashi Sachdeva, Mansi Sharma, B P Amrith, Shriya Vaidya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
crizotinib
entrectinib
ngs
nsclc
ros1
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2022;volume=5;issue=4;spage=692;epage=700;aulast=Nathany

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2022;volume=5;issue=4;spage=692;epage=700;aulast=Nathany

Similar Items